
### [MONDO:0019023](http://purl.obolibrary.org/obo/MONDO_0019023)
**Label:** cutaneous mastocytosis

**Subclasses:** [MONDO:0019315](http://purl.obolibrary.org/obo/MONDO_0019315) (diffuse cutaneous mastocytosis), [MONDO:0019316](http://purl.obolibrary.org/obo/MONDO_0019316) (Maculopapular cutaneous mastocytosis), 

**Corr. equiv. classes:** [Orphanet:79457](http://www.orpha.net/ORDO/Orphanet_79457), [Orphanet:79456](http://www.orpha.net/ORDO/Orphanet_79456), 

**Class expressions from DL-Learner:**

- [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 90.82%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 90.82%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 90.82%
- [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 85.36%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 85.36%
- [HP:0200036](http://purl.obolibrary.org/obo/HP_0200036) (Skin nodule) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 75.00%
- [HP:0200035](http://purl.obolibrary.org/obo/HP_0200035) (Skin plaque) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 75.00%
- [HP:0100845](http://purl.obolibrary.org/obo/HP_0100845) (Anaphylactic shock) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 75.00%
- [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 75.00%
- [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 75.00%
- [HP:0012384](http://purl.obolibrary.org/obo/HP_0012384) (Rhinitis) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 75.00%
- [HP:0011971](http://purl.obolibrary.org/obo/HP_0011971) (Dermatographic urticaria) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 75.00%
- [HP:0002242](http://purl.obolibrary.org/obo/HP_0002242) (Abnormality of the intestine) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 75.00%
- [HP:0002024](http://purl.obolibrary.org/obo/HP_0002024) (Malabsorption) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 75.00%
- [HP:0001072](http://purl.obolibrary.org/obo/HP_0001072) (Thickened skin) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 75.00%


